[
  {
    "date": "2023-12-30",
    "symbol": "LVTX",
    "period": "FY",
    "documenttype": "20-F",
    "documentregistrationstatement": "false",
    "documentshellcompanyreport": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "2023-12-31",
    "entityfilenumber": "001-40241",
    "entityregistrantname": "LAVA Therapeutics NV",
    "entityincorporationstatecountrycode": "P7",
    "entityaddresscountry": "NL",
    "entityaddressstateorprovince": "PA",
    "entityaddressaddressline1": "Yalelaan 62",
    "entityaddressaddressline2": "CM",
    "entityaddresscityortown": "Utrecht",
    "entityaddresspostalzipcode": 3584,
    "contactpersonnelemailaddress": "ir@lavatherapeutics.com",
    "contactpersonnelname": "Lava Therapeutics, Inc",
    "security12btitle": "Common shares, par value $0.14 per share",
    "tradingsymbol": "LVTX",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entitycommonstocksharesoutstanding": 26289087,
    "entitycentralindexkey": 1840748,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "icfrauditorattestationflag": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "auditorname": "PricewaterhouseCoopers",
    "auditorfirmid": 1395,
    "auditorlocation": "Eindhoven, The Netherlands",
    "revenuefromcontractswithcustomers": 6769000,
    "costofsales": 2546000,
    "costofmerchandisesold": 936000,
    "grossprofit": 3287000,
    "researchanddevelopmentexpense": 33814000,
    "generalandadministrativeexpense": 12726000,
    "operatingexpense": 46540000,
    "profitlossfromoperatingactivities": -43253000,
    "interestrevenueexpense": 2970000,
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": -1412000,
    "nonoperatingexpenses": -1558000,
    "profitlossbeforetax": -41695000,
    "incometaxexpensecontinuingoperations": 279000,
    "profitloss": -41974000,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": 2073000,
    "comprehensiveincome": -39901000,
    "basicearningslosspershare": -1.57,
    "dilutedearningslosspershare": -1.57,
    "weightedaverageshares": 26732556,
    "adjustedweightedaverageshares": 26732556,
    "propertyplantandequipment": 1602000,
    "rightofuseassets": 892000,
    "othernoncurrentassetsandsecuritydeposits": 319000,
    "noncurrentassets": 2813000,
    "tradeandothercurrentreceivables": 1459000,
    "currentprepaymentsandothercurrentassets": 1627000,
    "currentvalueaddedtaxreceivables": 240000,
    "currentheldtomaturityinvestments": 51340000,
    "cashandcashequivalents": 44231000,
    "currentassets": 98897000,
    "assets": 101710000,
    "issuedcapital": 3715000,
    "reserveofequitysettledemployeebenefits": 12005000,
    "reserveofexchangedifferencesontranslation": -10899000,
    "additionalpaidincapital": 194424000,
    "retainedearnings": -148067000,
    "equity": 51178000,
    "noncurrentcontractliabilities": 35000000,
    "noncurrentleaseliabilities": 591000,
    "noncurrentliabilities": 35591000,
    "tradeandothercurrentpayables": 4446000,
    "currentportionoflongtermborrowings": 5282000,
    "currentleaseliabilities": 440000,
    "currentaccruedexpensesandothercurrentliabilities": 4773000,
    "currentliabilities": 14941000,
    "liabilities": 50532000,
    "equityandliabilities": 101710000,
    "numberofsharesoutstanding": 26289087,
    "increasedecreasethroughsharebasedpaymenttransactions": -1976000,
    "foreigncurrencytranslationadjustment": 2073000,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangementshareoptionsforfeitedinsharebasedpaymentarrangementvalue": -5039000,
    "adjustmentsfordepreciationandamortisationexpense": 616000,
    "adjustmentsforunrealisedforeignexchangelossesgains": 1412000,
    "adjustmentsfordepreciationandamortisationexpenseofrightofuseassets": 662000,
    "adjustmentsforsharebasedpayments": 5039000,
    "adjustmentsforincometaxexpense": -279000,
    "adjustmentforamortizationofpremiumoninvestments": -1900000,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": 1870000,
    "adjustmentsforincreasedecreaseinvalueaddedtaxreceivable": 281000,
    "adjustmentsfordecreaseincreaseinprepaidexpensesandotherassets": 3385000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": 334000,
    "adjustmentsforincreasedecreaseinresearchanddevelopmentlicenseliabilities": -4797000,
    "adjustmentsforincreasedecreaseinotherliabilities": -3338000,
    "cashflowsfromusedinoperatingactivities": -38972000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 730000,
    "purchaseofinvestmentsotherthaninvestmentsaccountedforusingequitymethod": 90082000,
    "proceedsfromsalesofinvestmentsotherthaninvestmentsaccountedforusingequitymethod": 73177000,
    "cashflowsfromusedininvestingactivities": -17635000,
    "proceedsfromborrowingsclassifiedasfinancingactivities": 470000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 1041000,
    "cashflowsfromusedinfinancingactivities": -571000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": -57178000,
    "effectofexchangeratechangesoncashandcashequivalents": 1076000,
    "interestreceivedclassifiedasoperatingactivities": 3671000,
    "proportionofownershipinterestinsubsidiary": 1,
    "cashandcashequivalentsandcurrentinvestments": 95600000,
    "ifrsnumberofreportablesegments": 1,
    "postemploymentbenefitexpensedefinedcontributionplans": 600000,
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P10Y",
    "innovationboxtaxrate": 0.09,
    "applicabletaxrate": 0.258,
    "buyupfeeamount": 35000000,
    "transactionpriceallocatedtoremainingperformanceobligations": 50000000,
    "revenuefromcontractwithcustomerscumulativerevenuerecognized": 15165000,
    "accountsreceivable": 100000,
    "contractliabilities": 35000000,
    "researchanddevelopmentexpensepreclinicalandclinicaltrialexpenses": 20421000,
    "researchanddevelopmentexpensepersonnelrelatedexpenses": 6629000,
    "researchanddevelopmentexpenseresearchanddevelopmentactivitiesexpenses": 2680000,
    "researchanddevelopmentexpensefacilitiesandotherexpenses": 2356000,
    "researchanddevelopmentexpensesharebasedcompensationexpense": 1728000,
    "governmentgrants": 2000000,
    "generalandadministrativeexpensepersonnelrelatedexpenses": 3812000,
    "generalandadministrativeexpensesharebasedcompensationexpense": 3311000,
    "professionalfeesexpense": 2869000,
    "generalandadministrativeexpenseinsurancefacilitiesfeesandotherrelatedcosts": 2734000,
    "interestincomeexpenseondepositsandborrowingsnet": 3202000,
    "interestexpenseonleaseliabilities": 232000,
    "netforeignexchangeloss": 1400000,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 70300000,
    "deferredtaxassetnotrecognizedaccountingtotaxdifferences": -9700000,
    "unusedtaxlossesipdevelopmentcostactivatedinnovationboxtaxlaw": 72100000,
    "ipcapitalizeddevelopmentcostsexpensed": 14800000,
    "accountingprofit": -41695000,
    "taxexpenseincomeatapplicabletaxrate": -10757000,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 1268000,
    "taxeffectofforeigntaxrates": 75000,
    "taxeffectofchangeindeferredtaxassets": 9693000,
    "averageeffectivetaxrate": 0.007,
    "currenttaxexpenseincome": 279000,
    "deductibletemporarydifferencesforwhichnodeferredtaxassetrecognized": 86887000,
    "unrecognizeddeferredtaxassets": 157209000,
    "unrecognizeddeferredtaxassetstaxeffect": 40560000,
    "deferredtaxassets": 230000,
    "deferredtaxliabilities": 230000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 275000,
    "disposalspropertyplantandequipment": 23000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": 9000,
    "depreciationpropertyplantandequipment": 44000,
    "additionstorightofuseassets": 825000,
    "depreciationrightofuseassets": 662000,
    "rightofuseassetsincreasedecreasethroughnetexchangedifferences": 78000,
    "undiscountedleaseliabilitypaymentsdue": 550000,
    "leaseliabilityundiscountedexcessamount": 162000,
    "leaseliabilities": 1031000,
    "weightedaveragelesseesincrementalborrowingrateappliedtoleaseliabilitiesrecognisedatdateofinitialapplicationofifrs16": 0.156,
    "cashoutflowforleases": 1000000,
    "shorttermdepositsclassifiedascashequivalents": 10326000,
    "balanceswithbanks": 33905000,
    "parvaluepershare": 0.14,
    "numberofsharesauthorised": 45000000,
    "numberofsharesissuedandfullypaid": 26289087,
    "shareholdingpercentage": 0.206,
    "borrowingsinterestrate": 0.1,
    "borrowings": 5282000,
    "interestexpenseonborrowings": 500000,
    "averagecreditperiodondomesticpurchasesofcertaingoods": "P7D",
    "researchanddevelopmentexternalprojectcostscurrent": 2293000,
    "currentprovisionsforemployeebenefits": 1475000,
    "ifrsaccruedprofessionalfeescurrent": 523000,
    "othershorttermprovisions": 482000,
    "accruals": 400000,
    "reversalofprovisionsforcostofrestructuring": 500000,
    "tradeandotherpayables": 1000000,
    "numberofoutstandingshareoptions": 600457,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 879771,
    "numberofshareoptionsexpiredinsharebasedpaymentarrangement": 153389,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 118935,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 488972,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 0.01,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 3.17,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 0.01,
    "weightedaverageexercisepriceofshareoptionsexpiredinsharebasedpaymentarrangement2019": 3.75,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 2.76,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P7Y14D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardgrantedweightedaverageremainingcontractualterm": "P9Y1M20D",
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.884,
    "descriptionofoptionlifeshareoptionsgranted": 6.08,
    "weightedaveragesharepriceshareoptionsgranted2019": 1.06,
    "exercisepriceshareoptionsgranted2019": 1.4,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0346,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 2.39,
    "optionsexercisabletermduration": "P10Y",
    "ifrssharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod": "P36M",
    "ifrssharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "ifrssharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightsremainingpercentage": 0.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightstotalpercentage": 1,
    "incrementaldiscountrate": 0.1,
    "expensefromsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 5000000,
    "expensefromequitysettledsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 2000000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 3586000,
    "keymanagementpersonnelcompensationsharebasedpayment": 3503000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 104000,
    "keymanagementpersonnelcompensation": 7193000,
    "amountspayablerelatedpartytransactions": 100000,
    "directorsboardfees": 360000,
    "servicesreceivedrelatedpartytransactions": 360000,
    "financialassets": 44231000,
    "financialliabilities": 5282000,
    "averageforeignexchangerate": 7.4,
    "additionalgainslossesonexchangedifferencesontranslationrecognizedinprofitorloss": 5900000,
    "percentageofincreasedecreaseininterestrateorcurrencyrate": 0.01,
    "milestonepaymentreceivable": 7000000
  }
]